Skip to Content

Ritonavir

In the US, Ritonavir (ritonavir systemic) is a member of the following drug classes: antiviral boosters, protease inhibitors and is used to treat HIV Infection.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AE03,J05AX67

CAS registry number (Chemical Abstracts Service)

0155213-67-5

Chemical Formula

C37-H48-N6-O5-S2

Molecular Weight

720

Therapeutic Categories

Antiviral agent

Treatment of HIV infection

HIV protease inhibitor

Potent cytochrome P450 3A4 (CYP3A4) inhibitor

Chemical Name

5-tiazolylmetyl [(αS)-α-[(1S,3S)-1-hydroxy-3-[(2S)-2-[3-[(2-isopropyl-4-tiazolyl)metyl]-3-metylureido]-3-metylbutyramido]-4-phenylbutyl]phenetyl]carbamate

Foreign Names

  • Ritonavirum (Latin)
  • Ritonavir (German)
  • Ritonavir (French)
  • Ritonavir (Spanish)

Generic Names

  • Ritonavir (OS: USAN, BAN, JAN)
  • Abbott-84538 (IS)
  • ABT 538 (IS)
  • Ritonavir (PH: BP 2016, Ph. Eur. 8, Ph. Int. 4, USP 38)
  • Ritonavirum (PH: Ph. Eur. 8, Ph. Int. 4)

Brand Names

  • Alltera (Ritonavir and Lopinavir)
    Mylan, India
  • Aluvia (Ritonavir and Lopinavir)
    Abbott, China; Abbott, Ecuador; Abbott, Indonesia; Abbott, Kenya; Abbott, Serbia; Abbott, Tanzania; Abbott, South Africa; AbbVie, Thailand; AbbVie Deutschland, Bosnia & Herzegowina; Aesica Queenborough, Macedonia
  • Anzavir-R (Ritonavir and Atazanavir)
    Mylan, India
  • Busvir
    Conifarma, Argentina
  • Empetus
    Emcure, India
  • Kaletra (Ritonavir and Lopinavir)
    Abbott, Argentina; Abbott, Czech Republic; Abbott, Ecuador; Abbott, Greece; Abbott, Italy; Abbott, Portugal; Abbott, Romania; Abbott, Tunisia; Abbott, Taiwan; Abbott, Tanzania; Abbott, United States; Abbott, South Africa; Abbott Arzneimittel, Germany; Abbott Laboratories, Lithuania; Abbott Laboratories de Chile, Chile; AbbVie, Austria; AbbVie, Australia; AbbVie, Belgium; AbbVie, Canada; AbbVie, Switzerland; AbbVie, Germany; AbbVie, Denmark; AbbVie, Spain; AbbVie, Finland; AbbVie, France; AbbVie, United Kingdom; AbbVie, Hong Kong; AbbVie, Croatia (Hrvatska); AbbVie, Hungary; AbbVie, Ireland; AbbVie, Japan; AbbVie, Latvia; AbbVie, Netherlands; AbbVie, Norway; AbbVie, New Zealand; AbbVie, Sweden; AbbVie, Singapore; AbbVie, Thailand; AbbVie, Turkey; ABBVIE BIOPHARMACEUTICALS, Israel; Abbvie Farmacéuticos, Mexico; AbbVie Polska, Poland; AbbVie S.r.L., Slovakia; Aesica, Georgia; Cardinal Health, Oman; Changzheng-Xinkai, China
  • Lopimune (Ritonavir and Lopinavir)
    Cipla, Lebanon
  • Lopinavir/Ritonavir Accord (Ritonavir and Lopinavir)
    Accord, Netherlands
  • Lopinavir/Ritonavir Sandoz (Ritonavir and Lopinavir)
    Sandoz, Estonia; Sandoz, Netherlands
  • Loritec (Ritonavir and Lopinavir)
    Zifam India, Myanmar
  • Mai Ke Xin
    Meijisi Pharmaceutical, China
  • Norvir
    Abbott, Brazil; Abbott, China; Abbott, Czech Republic; Abbott, Ecuador; Abbott, Georgia; Abbott, Indonesia; Abbott, Ireland; Abbott, Latvia; Abbott, Netherlands; Abbott, Romania; Abbott, Slovakia; Abbott, Taiwan; Abbott, Tanzania; Abbott, United States; Abbott, South Africa; Abbott Laboratories, Croatia (Hrvatska); Abbott Laboratories, Lithuania; Abbott Laboratories de Chile, Chile; AbbVie, Austria; AbbVie, Australia; AbbVie, Belgium; AbbVie, Canada; AbbVie, Switzerland; AbbVie, Germany; AbbVie, Denmark; AbbVie, France; AbbVie, United Kingdom; AbbVie, Greece; AbbVie, Hong Kong; AbbVie, Hungary; AbbVie, Italy; AbbVie, Japan; AbbVie, Norway; AbbVie, New Zealand; AbbVie, Sweden; AbbVie, Slovenia; AbbVie, Thailand; AbbVie, Turkey; AbbVie, United States; AbbVie A/S, Iceland; ABBVIE BIOPHARMACEUTICALS, Israel; AbbVie Deutschland, Bosnia & Herzegowina; Abbvie Farmacéuticos, Mexico; AbbVie Polska, Poland; Aesica Queenborough LTD, Serbia
  • Norvir 8%
    AbbVie, Japan
  • Rinavo
    Mylan, India
  • Ritocom (Ritonavir and Lopinavir)
    Hetero, India
  • Ritomax
    Alkem, India
  • Ritomax-L (Ritonavir and Lopinavir)
    Alkem, India
  • Ritomune
    Cipla, Georgia; Cipla, India; Cipla, Lebanon
  • Ritonavir Abbott
    Abbott, Argentina
  • Ritonavir Mylan
    Mylan, Poland
  • Ritovir
    Hetero, India; Humax Pharmaceutical, Colombia
  • Synthivan (Ritonavir and Atazanavir)
    Cipla, India
  • Technivie (Ritonavir and Ombitasvir, + Paritaprevir)
    AbbVie, United States
  • Viekira Pak (Ritonavir and Dasabuvir, + Ombitasvir, + Paritaprevir)
    AbbVie, United States
  • Viekirax (Ritonavir and Ombitasvir, + Paritaprevir)
    AbbVie, Switzerland; AbbVie, Germany; AbbVie, France; AbbVie, United Kingdom; AbbVie, Ireland; AbbVie, Slovenia; AbbVie Polska, Poland; AbbVie S.r.L., Slovakia
  • Virataz-R (Ritonavir and Atazanavir)
    Hetero, India

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide